Clinical trial

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden

NCT06053749

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Avonex (IFNβ-1-a, Biogen Netherlands B.V) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Rebif (IFNβ-1-a, Merck Europe B.V.) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Extavia (IFNβ-1-b, Novartis Europharm Limited) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Betaseron (IFN-β-1-b, BAY86-5046, Bayer AG) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Plegridy (Peg IFNβ-1-a, Biogen Netherlands B.V) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MS disease modifying drugs (MSDMDs) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2024-03-20

PhaseN/A

Conditions

Multiple Sclerosis (MS)unresolved

Interventions

Avonex (IFNβ-1-a, Biogen Netherlands B.V)DRUG

Rebif (IFNβ-1-a, Merck Europe B.V.)DRUG

Extavia (IFNβ-1-b, Novartis Europharm Limited)DRUG

Betaseron (IFN-β-1-b, BAY86-5046, Bayer AG)DRUG

Plegridy (Peg IFNβ-1-a, Biogen Netherlands B.V)DRUG

MS disease modifying drugs (MSDMDs)DRUG

Sponsors & collaborators

Bayerlead sponsor

Biogen Netherlands B.Vcollaborator

Novartis Europharm Limitedcollaborator

Merck Europe B.V.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06053749 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.